XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article
Author Archives for Adeline Chauvigné
Xenothera news
19 September 2025XENOTHERA, created in 2014, is a Nantes-based biotech company which develops “humanized” polyclonal antibodies. Their technological platform is based on... View Article
GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year
Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology, held its ordinary Annual General Meeting, and... View Article
GlioCure finalises its seed capital with a financing from « French Tech Seed » and reports a second consecutive profitable year
19 September 2025Angers, May 12th, 2020 – GlioCure SAS, a biotech company specialised in neuro-oncology, held its ordinary Annual General Meeting, and... View Article
ENEN+ PROJECT
Attract, Retain and Develop New Nuclear Talents beyond Academic Curricula The ENEN+ project, co-funded by the EURATOM research and training... View Article
ENEN+ PROJECT
19 September 2025Attract, Retain and Develop New Nuclear Talents beyond Academic Curricula The ENEN+ project, co-funded by the EURATOM research and training... View Article
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
OSE Immunotherapeutics announced that the Company is committed to the fight against COVID-19. Its team of immunologists is actively working... View Article
OSE Immunotherapeutics Announces COVID-19 Prophylactic Vaccine Program
19 September 2025OSE Immunotherapeutics announced that the Company is committed to the fight against COVID-19. Its team of immunologists is actively working... View Article
Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
Phase 2 vaccine candidate, VLA15, is being evaluated for adult and pediatric indications in North America and Europe. Saint Herblain... View Article
Valneva and Pfizer Announce Collaboration to Co-Develop and Commercialize Lyme Disease Vaccine, VLA15
19 September 2025Phase 2 vaccine candidate, VLA15, is being evaluated for adult and pediatric indications in North America and Europe. Saint Herblain... View Article
Rare Diseases Research Challenges Call for proposals
The French Foundation for Rare Diseases, partner of the European Joint Programme for Rare Diseases EJPRD, is pleased to announce... View Article
Rare Diseases Research Challenges Call for proposals
19 September 2025The French Foundation for Rare Diseases, partner of the European Joint Programme for Rare Diseases EJPRD, is pleased to announce... View Article
New member | Restaart
Restaart laboratories offer a unique and ingenious multisensory experience that refuels our energy levels through short, fully guided, recovery sessions.... View Article
New member | Restaart
19 September 2025Restaart laboratories offer a unique and ingenious multisensory experience that refuels our energy levels through short, fully guided, recovery sessions.... View Article
#Coronavirus | Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19
Valneva is leveraging its technical and platform capabilities to develop an inactivated, whole virus vaccine candidate against the current coronavirus... View Article
#Coronavirus | Valneva and Dynavax Announce Collaboration to Advance Vaccine Development for COVID-19
19 September 2025Valneva is leveraging its technical and platform capabilities to develop an inactivated, whole virus vaccine candidate against the current coronavirus... View Article
#Coronavirus | Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response
NEWS PROVIDED BY Eurofins Medical Device Testing COVID-19 pandemic emergency is putting health care systems under severe strain, reflecting an... View Article
#Coronavirus | Eurofins Medical Device Testing commitment to support the safety and efficacy of devices used in the COVID-19 Crisis Response
19 September 2025NEWS PROVIDED BY Eurofins Medical Device Testing COVID-19 pandemic emergency is putting health care systems under severe strain, reflecting an... View Article
New member | CENTICH – VyV Group
The CENTICH is a private, non-profit organization, member of the French mutuality and the VyV group. It was created on... View Article
New member | CENTICH – VyV Group
19 September 2025The CENTICH is a private, non-profit organization, member of the French mutuality and the VyV group. It was created on... View Article